Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer. [electronic resource]
- Cancer chemotherapy and pharmacology 1985
- 132-4 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0344-5704
10.1007/BF00434351 doi
Adenocarcinoma--metabolism Animals Cell Count Cell Line Cell Survival--drug effects Doxorubicin--metabolism Drug Resistance Models, Biological Pancreatic Neoplasms--metabolism Time Factors